发明名称 CCR1 Inhibitors useful for the treatment of multiple myeloma and other disorders
摘要 The invention relates to the use of inhibitors of CCR1 for the treatment of cancers and osteolytic bone disorders. In some embodiments, the invention relates to methods for the treatment of multiple myeloma, smoldering multiple myeloma and secondary bone cancers.
申请公布号 US2009286823(A1) 申请公布日期 2009.11.19
申请号 US20080316901 申请日期 2008.12.17
申请人 MILLENNIUM PHARMACEUTICALS INC. 发明人 VEIBY OLE PETTER;ANDERSON KENNETH C.;VALLET SONIA
分类号 A61K31/4545;A61P35/00 主分类号 A61K31/4545
代理机构 代理人
主权项
地址
您可能感兴趣的专利